← USANA HEALTH SCIENCES INC USNA
Market Price
$13.35
Market Cap
$250.54M
P/E Ratio
23.01
Revenue (FY 2026)
0.0% YoY
$925.26M
3-Yr CAGR: 0.2%
Net Income
↑6.7% YoY
$11.48M
Net Margin: 1.2%
Free Cash Flow
0.0% YoY
$8.53M
FCF Yield: 3.40%
EPS (Diluted)
0.0% YoY
$0.58
Basic: $0.58
Return on Equity
Efficiency
2.2%
ROA: 1.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (USNA)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2021: Revenue YoY (+0.0%) is identical to Gross Profit YoY (+0.0%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
- FY 2021: Revenue YoY (+0.0%) is identical to Net Income YoY (+0.0%). Verify the underlying Revenue and Net Income values for FY 2021 and FY 2020.
- FY 2026: Revenue YoY (+0.0%) is identical to Gross Profit YoY (+0.0%). Verify the underlying Revenue and Gross Profit values for FY 2026 and FY 2025.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $1,047.3M | — | $867.9M | $62.5M | — | $2.53 | — | $123.8M | $110.6M | — |
| FY 2018 | $1,189.2M | +13.6% | $988.5M | $126.2M | +101.8% | $5.12 | +102.4% | $152.1M | $140.7M | +27.2% |
| FY 2019 | $1,060.9M | -10.8% | $873.4M | $100.5M | -20.4% | $4.41 | -13.9% | $126.7M | $110.2M | -21.7% |
| FY 2020 | $1,134.6M | +7.0% | $925.5M | $124.7M | +24.0% | $5.86 | +32.9% | $160.4M | $145.3M | +31.9% |
| FY 2021 | $1,134.6M | 0.0% | $925.5M | $124.7M | 0.0% | $5.86 | 0.0% | $160.4M | $145.3M | 0.0% |
| FY 2022 | $998.6M | -12.0% | $780.7M | $69.3M | -44.4% | $3.59 | -38.7% | $103.9M | $93.5M | -35.7% |
| FY 2023 | $921.0M | -7.8% | $744.3M | $63.8M | -8.0% | $3.30 | -8.1% | $70.6M | $56.1M | -40.0% |
| FY 2024 | $854.5M | -7.2% | $693.3M | $42.0M | -34.1% | $2.19 | -33.6% | $61.0M | $50.9M | -9.3% |
| FY 2025 | $925.3M | +8.3% | $724.4M | $10.8M | -74.4% | $0.58 | -73.5% | $22.3M | $8.5M | -83.3% |
| FY 2026 | $925.3M | 0.0% | $724.4M | $11.5M | +6.7% | $0.58 | 0.0% | $22.3M | $8.5M | 0.0% |
Valuation
Market Price
$13.35
Market Cap
$250.54M
Enterprise Value
N/A
P/E Ratio
23.01
P/B Ratio
0.46
FCF Yield
3.40%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
78.29%
Operating Margin
5.73%
Net Margin
1.24%
Return on Equity (ROE)
2.15%
Return on Assets (ROA)
1.54%
Asset Turnover
1.25x
Revenue 3-Yr CAGR
0.15%
Financial Health & Liquidity
Current Ratio
0.28
Cash Ratio
1.63
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$158.38M
Total Debt
N/A
Book Value / Share
$28.87
Cash Flow Efficiency
Operating Cash Flow
$22.35M
Capital Expenditures (CapEx)
$13.82M
Free Cash Flow
$8.53M
OCF / Revenue
2.42%
FCF / Revenue
0.92%
FCF 3-Yr CAGR
-46.65%
Per Share Metrics
EPS (Diluted)
$0.58
EPS (Basic)
$0.58
Dividends / Share
N/A
Book Value / Share
$28.87
EPS YoY Growth
0.00%
Balance Sheet (FY 2026)
Total Assets
$742.91M
Total Liabilities
$156.64M
Stockholders' Equity
$533.10M
Current Assets
$27.42M
Current Liabilities
$97.30M